期刊名称：INFLAMMATORY BOWEL DISEASES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal Description - Inflammatory Bowel Diseases® is the first journal dedicated exclusively to IBD. It covers all topics of interest to the professional treating patients or conducting research in this burgeoning field. Each bi-monthly issue features original, peer-reviewed articles in clinical and basic science areas, as well as invited in-depth reviews of key treatment issues and groundbreaking research. Coverage includes articles highlighting the unique and important issues in pediatric IBD, as well as articles pertaining to adult patients. Also included are critical examinations of the design and results of recent clinical trials; elucidative discussions of controversial diagnostic and management issues and techniques; and summaries of significant articles from around the world with relevant commentary by experts in the field.
In Every Issue of Inflammatory Bowel Diseases® ...
- Controversies in IBD
- Basic Science Review
- Case Reports
ISSN: 1078-0998
Online ISSN: 1536-4844
Frequency: Six issues per year
Instructions to Authors
Scope
The focus of the journal Inflammatory Bowel Diseases® is to bring the most current information in the clinical and basic sciences to all physicians caring for patients with inflammatory bowel diseases, and to investigators performing research in inflammatory bowel diseases and related fields. The journal will publish peer-reviewed manuscripts and review articles in basic and clinical sciences, updates on clinical trials, reviews of the current literature, case reports, editorials, and other features.
Ethical/Legal Considerations A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the journal, its editors, or the publisher. All manuscripts must be submitted online through the journal's website at https://ibd.edmgr.com. See submission instructions below, under "Online manuscript submission."
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: A copy of the journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form must be signed by all authors and submitted to Molly Sullivan, Inflammatory Bowel Diseases, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106.
Permissions: Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner (usually the publisher) and the original author, along with complete information as to the source.
Manuscript Submission
Online manuscript submission: All manuscripts must be submitted online through the new website at https://ibd.edmgr.com. First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Molly Sullivan, msulliva@LWW.com, 215-521-8470, fax 215-521-8488. Requests for help and other questions will be addressed in the order received.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
Unstructured abstract and key words: Limit the abstract to 250 words. It must be factual and comprehensive. Do not cite references in the abstract. Limit the use of abbreviations and acronyms, and avoid general statements (e.g., "the significance of the results is discussed"). List three to five key words.
Text: For full-length research articles, organize the manuscript in the following sequence: Abstract and Key Words, Introduction, Materials and Methods, Ethical Considerations, Results, Discussion, Acknowledgment, References, Tables, and Figure Legends. Original Research Articles: Authors are encouraged to submit articles in basic or clinical science. Review Articles of exceptional merit will also be accepted. Contributors should communicate with the Editors before submitting a review. Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. Acknowledge all forms of support, including pharmaceutical industry support, in an Acknowledgment paragraph.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data, such as papers submitted but not yet accepted for publication, personal communications, in parentheses in the text. If there are more than three authors, only name the first three authors and then use et al. For abbreviations of journal names, refer to List of Journals Indexed in Index Medicus. This can be accessed at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Gudlaugsdottir S, van Dekken H, Stijnen T, et al. Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis. J Clin Gastroenterol. 2002;34:536?40
Book chapter
2. Tobin RW, Kimmey MB. Painful diseases of the gastrointestinal tract. In: Loeser JD, ed. Bonica's Management of Pain. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1269?292.
Entire book
3. Rohen JW, Yokochi C, LŸtjen-Drecoll E. Color Atlas of Anatomy: A Photographic Study of the Human Body. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002
Software
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22?7. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997
Figures:Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographsÑradiographs, CT scans, and so onÑand scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such as Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used. Cite figures consecutively on the site, and number them in the order in which they are discussed.
Figure legends:Legends must be submitted for all figures. They should be brief and specific, and they should appear after the text and before the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures:The journal accepts for publication color figures that will enhance the article. Authors who submit color figures will receive an estimate of the cost for color reproduction. The cost of printing color illustrations will be charged to the author. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Tables:Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file. Cite tables consecutively in the text, and number them in that order. Key each on a separate sheet, and include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug. Capitalize the trade names of drugs and place them in parentheses after the generic names. To comply with trademark law, include the name and location (city and state in USA; city and country outside USA) of the manufacturer of any drugs, supplies, or equipment mentioned in the manuscript. Use the metric system to express units of measure and degrees Celsius to express temperatures, and use SI units rather than conventional units.
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (e.g., reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected pages to the publisher. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style should be allowed to stand if they do not alter the authors' meaning. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106, with any questions.
Publisher's contact: Return corrected page proofs, reprint order form, and any other related materials to Project Editor, Inflammatory Bowel Diseases, Lippincott Williams & Wilkins, 351 West Camden Street, Baltimore, MD 21201, fax 410-528-4187.
Editorial Board
EditorsRobert Burakoff, M.D., M.P.H.
Chief of Clinical Gastroenterology
Division of Gastroenterology
Brigham & Women's Hospital
Boston, MA
Richard P. MacDermott, M.D.
Professor of Medicine
Head, Division of Gastroenterology
The Albany Medical College
Albany, New York
|
Section Editors |
Basic Science Articles
Richard S. Blumberg, M.D.
Boston, Massachusetts
Scott Plevy, M.D.
New York, New York
Joel Weinstock, M.D.
Iowa City, Iowa
Clinical Reviews
Jean-Frederic Colombel, M.D.
Lille, France
Gary R. Lichtenstein, M.D.
Philadelphia, Pennsylvania
Paul Rutgeerts, M.D., Ph.D.
Leuven, Belgium
William Sandborn, M.D.
Rochester, Minnesota
J¨¹rgen Schölmerich, M.D.
Regensburg, Germany
Clinical Articles
Maria T. Abreu, M.D.
Los Angeles, California,
Anders Ekbom, M.D.
Stockholm, Sweden
Kim L. Isaacs, M.D., Ph.D.
Chapel Hill, North Carolina
Bret Lashner, M.D.
Cleveland, Ohio
Edward Loftus, M.D.
Rochester, Minnesota
Theodore Bayless, M.D.
Baltimore, Maryland,
A. Hillary Steinhart, M.D.
Toronto, Ontario, Canada
William J. Tremaine, M.D.
Rochester, Minnesota
Controversies in IBD
Robert Baldassano, M.D.
Philadelphia, Pennsylvania,
Charles Bernstein, M.D.
Winnipeg, Manitoba, Canada
Russell Cohen, M.D.
Chicago, Illinois
Hankje JC Escher, M.D.
Amsterdam, The Netherlands
Robin McLeod, M.D.
Toronto, Ontario, Canada
Daniel H. Present, M.D.
New York, New York
Sander van Deventer, M.D.
Amsterdam, The Netherlands
Scott A. Strong, M.D.
Cleveland, OH
Selected Summaries
Joshua R. Korzenik, M.D.
St. Louis, Missouri
Bruce E. Sands, M.D.
Boston, Massachusetts
|
Basic Science Reviews
Claudio Fiocchi, M.D.
Cleveland, Ohio
Stephen P. James, M.D.
Baltimore, Maryland
Yashwant R. Mahida, M.D.
Nottingham, England, U.K.
Fergus Shanahan, M.D.
Cork, Ireland
William Stenson, M.D.
St. Louis, Missouri
Stephan Targan, M.D.
Los Angeles, California
Basic Science on the Cutting Edge
Fabio Cominelli, M.D.
Charlottesville, Virginia
Charles Elson, III, M.D.
Birmingham, Alabama
Alan D. Levine, Ph.D.
Cleveland, Ohio
Lloyd Mayer, M.D.
New York, New York
R. Balfour Sartor, M.D.
Chapel Hill, North Carolina
Clinical Viewpoints
Cosimo Prantera, M.D.
Rome, Italy
Genetics
Steven Brant, M.D.
Baltimore, Maryland
Richard Duerr, M.D.
Pittsburgh, Pennsylvania
Derek P. Jewell, M.D.
Oxford, England, U.K.
J. Satsangi, M.D.
Oxford, England, U.K.
Stefan Schreiber, M.D.
Kiel, Germany
Pediatric Articles
Marla Dubinsky, M.D.
Los Angeles, California
Richard J. Grand, M.D.
Boston, Massachusetts
Jean Perrault, M.D.
Rochester, Minnesota
Ernest G. Seidman, M.D.
Montr¨¦al, Qu¨¦bec, Canada
|
Editorial Board |
James Becker, M.D.
Boston, Massachusetts, U.S.A.
David G. Binion, M.D.
Whitefish Bay, Wisconsin, U.S.A.
Alan L. Buchman, M.D.
Houston, Texas, U.S.A.
Massimo Campieri, M.D.
Bologna, Italy
Christine Cartwright, M.D.
Stanford, California, U.S.A.
Eugene Chang, M.D.
Chicago, Illinois, U.S.A.
Mitsuro Chiba, M.D.
Akita City, Japan
Stephen Collins, M.D.
Hamilton, Ontario, Canada
Carmen Cuffari, M.D.
Baltimore, Maryland, U.S.A.
Kiron Das, M.D., Ph.D.
New Brunswick, New Jersey, U.S.A.
Geet D'Haens, M.D.
Leuven, Belgium
Francis Farraye, M.D.
Boston, MA,
Victor W. Fazio, M.D.
Cleveland, Ohio, U.S.A.
Brian G. Feagan, M.D.
London, Ontario, Canada
George D. Ferry, M.D.
Houston, Texas, U.S.A.
Warren Finkelstein, M.D.
Glen Ridge, New Jersey, U.S.A.
Glenn T. Furuta, M.D.
Boston, Massachusetts, U.S.A.
Ivan Fuss, M.D.
Bethesda, Maryland, U.S.A.
Anne M. Griffiths, M.D.
Toronto, Ontario, Canada
Matthew Grisham, M.D.
Shreveport, Louisiana, U.S.A.
Stephen B. Hanauer, M.D.
Chicago, Illinois, U.S.A.
Maria Oliva-Hemker, M.D.
Baltimore, Maryland, U.S.A.
Toshifumi Hibi, M.D.
Tokyo, Japan
Humphrey H. Hodgson, M.D.
London, England, U.K.
Jeffrey S. Hyams, M.D.
Hartford, Connecticut, U.S.A.
Steven H. Itzkowitz, M.D.
New York, New York, U.S.A.
Gunnar Järnerot, M.D., Ph.D.
Örebro, Sweden
Michael Kamm, M.D.
Middlesex, England
Jeffry Katz, M.D.
Cleveland, Ohio, U.S.A.
Ciaran Kelly, M.D.
Boston, Massachusetts, U.S.A.
Barbara S. Kirschner, M.D.
Chicago, Illinois, U.S.A.
Burton I. Korelitz, M.D.
New York, New York, U.S.A.
Thomas LaMont, M.D.
Boston, Massachusetts, U.S.A.
James D. Lewis, M.D.
Philadelphia, Pennsylvania, U.S.A.
|
Herbert Lochs
Berlin, Germany
Edward V. Loftus, M.D.
Rochester, Minnesota, U.S.A.
Averil I. Ma, M.D.
Chicago, Illinois, U.S.A.
Thomas MacDonald, Ph.D.
London, England, U.K.
David R. Mack, M.D.
Omaha, Nebraska, U.S.A.
Uma Mahadevan, M.D.
San Francisco, CA, U.S.A.
Juan Malagelada, M.D.
Barcelona, Spain
Jim Markowitz, M.D.
Manhasset, New York, U.S.A.
Philip B. Miner, M.D.
Oklahoma City, Oklahoma, U.S.A.
Markus Neurath, M.D.
Mainz, Germany
Francesco Pallone, M.D.
Catanzaro, Italy
Amado Salvador Peña, M.D.
Amsterdam, The Netherlands
Mark A. Peppercorn, M.D.
Boston, Massachusetts, U.S.A.
Theresa T. Pizarro, Ph.D.
Charlottesville, Virginia, U.S.A.
Daniel K. Podolsky, M.D.
Boston, Massachusetts, U.S.A.
Fiona Powrie
Oxford, England
Daniel Rachmilewitz
Tel Aviv, Israel
Hans Christian Reinecker, M.D.
Boston, Massachusetts, U.S.A.
Patricia L. Roberts, M.D.
Burlington, Massachusetts, U.S.A.
Robert Sandler, M.D.
Chapel Hill, North Carolina, U.S.A.
Ellen Scherl, M.D.
Fort Lee, New Jersey, U.S.A.
Samir Shah, M.D.
Providence, Rhode Island, U.S.A.
Charles A. Sninsky, M.D.
Gainesville, Florida, U.S.A.
Eduard Stange, M.D.
Stuttgart, Germany
Warren Strober, M.D.
Bethesda, Maryland, U.S.A.
Lloyd R. Sutherland, M.D.
Calgary, Alberta, Canada
Vasundhara K. Tolia, M.D.
Detroit, Michigan, U.S.A.
John F. Valentine, M.D.
Gainesville, Florida, U.S.A.
W. Allan Walker, M.D.
Charleston, Massachusetts, U.S.A.
John Wallace, Ph.D.
Calgary, Alberta, Canada
Harland S. Winter, M.D.
Boston, Massachusetts, U.S.A.
Bruce Yacyshyn, M.D.
Edmonton, Alberta, Canada
Martin Zeitz, M.D.
Berlin, Germany
|
|
刊名字顺( Alphabetical List of Journals):
返回页首 